Historical record - last NADAC publication: 4/17/2024
Product Information
TOPIRAMATE 200 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0880 per EA under NDC 62756071213. Its NADAC has been published 547 times since Nov 28, 2013.
Strength
200 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756071213
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/17/2024
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA090278On Market Since
3/27/2009
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 200 MG TABLET has been published 547 times since Nov 28, 2013, and over the history we have for it it has declined 27.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0880 per EA |
|---|---|
| All-time high | $0.1389 (Jul 15, 2015) |
| All-time low | $0.0880 (Apr 17, 2024) |
| Median price | $0.1174 |
| Average price | $0.1158 |
| Largest weekly change | -19.3% (Apr 17, 2024) |
| Weeks tracked | 547 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 200 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.0880 per EA (NDC 62756071213), effective May 15, 2024.
How has the price of TOPIRAMATE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 200 MG TABLET has declined 27.3%. It has been tracked across 547 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 200 MG TABLET?
Since Nov 28, 2013, the NADAC for TOPIRAMATE 200 MG TABLET has ranged from a low of $0.0880 (Apr 17, 2024) to a high of $0.1389 (Jul 15, 2015), with a median of $0.1174 per EA.
Are there cheaper alternatives to TOPIRAMATE 200 MG TABLET?
12 NADAC-published products share the same active ingredient, strength, and dosage form as TOPIRAMATE 200 MG TABLET, but none are currently priced below it.
Who manufactures TOPIRAMATE 200 MG TABLET?
TOPIRAMATE 200 MG TABLET (NDC 62756071213) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification